TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026)
TherapeuticsMD (TXMD) reported Other Non-Current Assets of $419000.0 for Q1 2026, up 98.58% on a YoY basis from $211000.0 in Q1 2025, and down 5.63% quarter-over-quarter from $444000.0 in Q4 2025.
TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
TherapeuticsMD has reported Other Non-Current Assets for 17 years, with the latest figure at $419000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 98.58% year-over-year to $419000.0; the trailing twelve-month figure through Mar 2026 stood at $419000.0 (up 98.58% YoY), and the FY2025 full-year result was $444000.0, up 241.54% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $419000.0, down from $444000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $470000.0 in Q3 2025, with the low at $58000.0 in Q4 2023.
- Historically, Other Non-Current Assets has averaged $243764.7 across 5 years, with a median of $253000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 99.48% — and 2025, when it surged 710.34%.
- TherapeuticsMD's Other Non-Current Assets stood at $253000.0 in 2022, then plunged by 77.08% to $58000.0 in 2023, then jumped by 124.14% to $130000.0 in 2024, then soared by 241.54% to $444000.0 in 2025, then retreated by 5.63% to $419000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $419000.0 (Q1 2026), $444000.0 (Q4 2025), and $470000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | 419,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 428,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 253,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 253,000.00 |
| Jun 30, 2022 | 254,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 48.70 Mn |
| Sep 30, 2021 | 253,000.00 |
| Jun 30, 2021 | 253,000.00 |